Firefly Neuroscience, Inc. - Common Stock AIFF 深 滬
已收盤 08-29 16:00:00 美东时间
2.65
+0.010
+0.38%
華盛通- 最 高2.71
- 今 開2.67
- 成交量 55.11万股
- 最 低 2.61
- 昨 收 2.64
- 總市值 3408.19万
- 52周最高 17.20
- 市盈率 靜 --
- 換手率 0.00%
- 52周最低 1.86
- 委 比 38.26%
- 總股本 1286.11万
- 歷史最高 180.00
- 量 比 0.03
- 振 幅 3.79%
- 歷史最低 1.86
- 每 手 1
- 風險率 1.37%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Gainers Invivyd (NASDAQ:IVVD) stock increased by 132.3% to $1.3 during Tuesday...
08-26 20:09
Firefly Neuroscience Launches AI-Powered CLEAR Platform To Deliver Cleaner, Faster EEG Data Using NVIDIA GPUs
Firefly Neuroscience, Inc. ("Firefly" or the "Company") (NASDAQ:AIFF), an Artificial Intelligence ("AI") company developing innovative solutions that improve brain health outcomes for patients with neurological and
08-26 19:49
Firefly Neuroscience Successfully Deploys NVIDIA L40S GPU Acceleration to Power Next-Gen ‘CLEAR’ Platform
Firefly Neuroscience launched its new 'CLEAR' Platform, a next-generation EEG preprocessing technology powered by NVIDIA's L40S GPU. The platform significantly improves EEG data quality, reduces noise, and cuts processing times by 60-80%, enabling better detection of neural biomarkers for neurological and psychiatric conditions. This breakthrough supports Firefly's mission to advance brain health research and clinical care through AI-driven insig...
08-26 11:45
Firefly Neuroscience Q2 EPS $(0.14) Up From $(0.24) YoY, Sales $299.000K Up From $10.000K YoY
Firefly Neuroscience (NASDAQ:AIFF) reported quarterly losses of $(0.14) per share. This is a 41.67 percent increase over losses of $(0.24) per share from the same period last year. The company reported $299.000 thousand
08-14 05:09
Firefly Neuroscience Teams With German Hospital to Study Rare Brain Disorders Using AI and EEG
Firefly Neuroscience, Inc. ("Firefly" or the "Company") (NASDAQ:AIFF), an Artificial Intelligence ("AI") company developing innovative solutions that improve brain health outcomes for patients with neurological and
07-14 19:47
Firefly Inks Latest Commercial Agreement for Use of its FDA-Cleared BNA™ Platform in Groundbreaking Precision Neuroscience Research
Firefly Neuroscience与海德堡大学医院合作，开展关于15q13.3 CNVs的EEG生物标志物研究，旨在揭示罕见遗传条件下的脑功能架构，支持诊断和治疗，计划于2026年完成。
07-14 11:45
ChatGPT成功助诊疑难杂症 微软实现AI医疗重大突破！AI医疗是风口吗？
TradingKey - 因OpenAI联合创始人Greg Brockman转发了一条帖子，AI医疗再一次进入公众视野并引起热议。
07-07 10:22
Firefly Neuroscience to be Added to the Russell Microcap® Index
Firefly Neuroscience, Inc. has been added to the Russell Microcap® Index, reflecting significant progress since its Nasdaq listing less than a year ago. Firefly has made breakthroughs including a cognitive brain age biomarker discovery, joining NVIDIA Connect, expanding through the acquisition of Evoke Neuroscience, and developing a new method to distinguish between cognitive decline stages. CEO Greg Lipschitz emphasizes enhanced visibility for i...
06-23 12:05
Firefly Neuroscience shares are trading higher after the company. announced a breakthrough in Alzheimer's detection using combined EEG/ERP and vMRI.
Firefly Neuroscience shares are trading higher after the company. announced a b...
06-20 20:57
Firefly Neuroscience Researchers Uncover Powerful New Way of Objectively Measuring SCD, MCI, and Dementia in Alzheimer’s Patients
A study published by Firefly Neuroscience highlights the effectiveness of combining EEG/ERP and vMRI for accurately distinguishing between subjective cognitive decline (SCD), mild cognitive impairment (MCI), and dementia. The research, involving real-world data from memory clinic patients, found that using three EEG measures—reaction time, commission errors, and P300b amplitude—could categorize subjects with 80% accuracy. Adding vMRI data, partic...
06-20 11:45
